Management of empagliflozin and ertugliflozin may be suboptimal following an insurance carrier’s formulary updates. Pharmacists may improve the management.
Ashwini B. Navathe, PharmD, BCPS, BCPPS
Advertisement
Articles by Ashwini B. Navathe, PharmD, BCPS, BCPPS
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on AJMC
1
US Employer Health Care Costs Projected to Rise 9.5% in 2027
2
FDA Clears First Single-Biomarker Blood Test for Alzheimer
3
Lung Cancer Task Force Maps Research Roadmap to Close Survival Gap
4
New York Experts Push for Coordinated Obesity Care Teams
5